X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 26/Jun 11:46

Charles River (CRL) Inks CDMO Deal With Gates Institutes

Charles River (CRL) signs a lentiviral vector contract development and manufacturing organization agreement with Gates Institute to help develop chimeric antigen receptor (CAR) T-cell therapies.

Articles similaires

Sorry! Image not available at this time

Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies Modified to Minimize Burden on Healthcare Delivery System

drugs.com - 26/Jun 09:25

Audience: Health Professional June 26, 2024 -- Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell...

Sorry! Image not available at this time

Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health

zacks.com - 27/Jun 13:43

Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics'...

Sorry! Image not available at this time

Charles River's (CRL) RMS Growth Aids Amid FX Headwind

zacks.com - 27/Jun 14:23

Charles River (CRL) broadens the scope of its products and services across the drug discovery and early-stage development continuum through focused...

Amara Raja signs agreement with GIB EnergyX for lithium-ion battery technology

hindustantimes.com - 24/Jun 15:25

Amara Raja holding a 35% market share of India's battery manufacturing, signs lithium-ion battery technology pact.

Vestigo inks PETRONAS deal in Sabah

thestar.com.my - 27/Jun 16:00

Petroliam Nasional Bhd (PETRONAS) has inked a small field asset production-sharing contract (PSC) with Vestigo Petroleum Sdn Bhd for a discovered...

Sorry! Image not available at this time

State Street (STT) Inks Deal for Enhanced Digital Solutions

zacks.com - 27/Jun 13:55

State Street (STT) enters into a partnership agreement with Galaxy Digital to enhance its digital-based offerings. This move aligns with the company's...

Sorry! Image not available at this time

Barrington James: Business Development Director

pharmiweb.com - 22/Jun 00:00

Competitive: Barrington James: Company Profile: We are a full-service contract research organisation (CRO) and Contract Development Manufacturing...

Sorry! Image not available at this time

RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors

financialpost.com - 25/Jun 07:02

EDINBURGH, Scotland & BOSTON — RoslinCT, a leading cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), is...

IIB inks strategic partnership with TM-Nxera

thestar.com.my - 19/Jun 08:18

ISKANDAR PUTERI: Iskandar Investment Bhd (IIB), the master developer of Iskandar Puteri, via River Retreat Sdn Bhd, has entered into a strategic...